We have a vertically Integrated, R&D organization able to offer development services using a General Contractor model: we can plan, manage and execute entire development projects on behalf of our clients. We are specialized in the development of oral and topical formulations in all healthcare regulatory fields: from pharmaceuticals to nutraceuticals, from dermocosmetics to Medical Devices thanks to a strong know how and experience over the last 20 years with primary global healthcare companies.
APR utilizes a unique Project Design Planning focused on a scientific driven risk/benefit analysis where all regulatory, investment and product classification aspects are analyzed; at the same time APR uses an Integrated Project Development approach where all phases of product development are harmonized and centrally managed in order to maximize time and cost efficiency in executing development activities.
On October 18th 2009, after official quality audit and inspection to APR's R&D labs, Standard Operative Procedures and Quality Assurance system, the Company received final ISO 13485 Certification from the certifying body TüV for the development of Medical Device Products. In addition to this certification, APR is maintaining official recognition from the Swiss Health Authority (SwissMedic) as company working under strict Good Manufacturing Practices (GMP) for the chemical, physical and biochemical quality control of medicinal products. APR is registered since 2001 as a pharmaceutical company in Switzerland working under Good Distribution Practice (GDP) despite APR has not any Sales & Marketing activities.